Yee Leung

ORCID: 0000-0003-0349-8652
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Endometriosis Research and Treatment
  • Uterine Myomas and Treatments
  • Cervical Cancer and HPV Research
  • PARP inhibition in cancer therapy
  • Cancer Genomics and Diagnostics
  • Intraperitoneal and Appendiceal Malignancies
  • Cancer-related molecular mechanisms research
  • Reproductive Biology and Fertility
  • Genetic factors in colorectal cancer
  • Gynecological conditions and treatments
  • DNA Repair Mechanisms
  • Lymphatic System and Diseases
  • Simulation-Based Education in Healthcare
  • Ovarian function and disorders
  • Reproductive System and Pregnancy
  • Cancer-related Molecular Pathways
  • Cancer Mechanisms and Therapy
  • Urinary and Genital Oncology Studies
  • Gastric Cancer Management and Outcomes
  • Prenatal Screening and Diagnostics
  • Sperm and Testicular Function
  • Pregnancy-related medical research
  • Ectopic Pregnancy Diagnosis and Management

King Edward Memorial Hospital
2016-2025

The University of Western Australia
2016-2025

Women and Infants Research Foundation
2018-2024

Royal Women's Hospital
2024

QIMR Berghofer Medical Research Institute
2024

Australia New Zealand Gynaecological Oncology Group
2020-2022

Vancouver General Hospital
2020

University of British Columbia
2020

Chinese University of Hong Kong
2018-2019

University Cancer Center Hamburg
2018

<h3>Importance</h3> Standard treatment for endometrial cancer involves removal of the uterus, tubes, ovaries, and lymph nodes. Few randomized trials have compared disease-free survival outcomes surgical approaches. <h3>Objective</h3> To investigate whether total laparoscopic hysterectomy (TLH) is equivalent to abdominal (TAH) in women with treatment-naive cancer. <h3>Design, Setting, Participants</h3> The Laparoscopic Approach Cancer Endometrium (LACE) trial was a multinational, equivalence...

10.1001/jama.2017.2068 article EN JAMA 2017-03-28

10.1038/s41379-019-0302-0 article EN publisher-specific-oa Modern Pathology 2019-06-25

Intrauterine levonorgestrel (LNG-IUD) is used to treat patients with endometrial adenocarcinoma (EAC) and hyperplasia atypia (EHA) but limited evidence available on its effectiveness. The study determined the extent which LNG-IUD or without metformin (M) weight loss (WL) achieves a pathological complete response (pCR) in EAC EHA.This phase II randomized controlled clinical trial enrolled histologically confirmed, clinically stage 1 FIGO grade EHA; body mass index > 30 kg/m2; depth of...

10.1016/j.ygyno.2021.01.029 article EN cc-by-nc-nd Gynecologic Oncology 2021-03-21

Obesity is common in endometrial cancer and surgery for these patients challenging. We compared total laparoscopic hysterectomy (TLH) with abdominal (TAH) respect to feasibility (operating time, estimated blood loss, length of hospital stay, conversion laparotomy) safety (perioperative morbidity mortality) a retrospective analysis 78 morbidly obese cancer. Analysis based on the intention treat. The treat was TLH 47 it could be successfully completed 42 (89.4%). mean weight all 118.7 kg,...

10.1111/j.1525-1438.2005.15223.x article EN International Journal of Gynecological Cancer 2005-03-01

Abstract Purpose: Women with epithelial ovarian cancer generally have a poor prognosis; however, subset of patients has an unexpected dramatic and durable response to treatment. We sought identify clinical, pathological, molecular determinants exceptional survival in women high-grade serous (HGSC), disease associated the majority deaths. Experimental Design: evaluated histories 2,283 and, after applying stringent clinical pathological selection criteria, identified 96 HGSC that represented...

10.1158/1078-0432.ccr-17-1621 article EN Clinical Cancer Research 2017-10-23

Introduction Sentinel lymph node dissection is widely used in the staging of endometrial cancer. Variation surgical techniques potentially impacts diagnostic accuracy and oncologic outcomes, poses barriers to comparison outcomes across institutions or clinical trial sites. Standardization technique quality assessment tools are critical conduct trials. By identifying mandatory prohibited steps sentinel (SLN) cancer, purpose this study was develop validate a competency tool for use assurance....

10.1136/ijgc-2020-002315 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2021-03-04

Anti-N-methyl D-aspartate receptor (NMDAR) encephalitis is a recently described severe neurological disorder predominantly affecting young women, which presents with psychosis, memory deficits, seizures, and encephalopathy, often requiring prolonged hospitalization. The condition frequently associated an underlying neoplasm, most ovarian teratoma, in such cases appears to be para-neoplastic, immune-mediated encephalopathy. histologic features of the teratomas anti-NMDAR have seldom been...

10.1097/pgp.0b013e31824a1de2 article EN International Journal of Gynecological Pathology 2012-07-25

To describe survival patterns in a nationally complete cohort of Australian women with epithelial ovarian cancer, by sociodemographic and clinical factors. All 1192 diagnosed invasive cancer 2005 were identified through state-based registries. We obtained detailed information from their medical records 2009 updated data 2012. Crude 3-year, 5-year 7-year rates; 3-year conditional survival; hazard ratios (HRs) for the association participant characteristics survival, multivariable Cox...

10.5694/mja14.00132 article EN The Medical Journal of Australia 2014-08-28

Our objective was to validate the prognostic role of chemotherapy response score (CRS), which has been proposed for measuring tumor neoadjuvant in patients with high-grade serous tubo-ovarian carcinoma, predicting progression-free survival (PFS) and overall (OS).A retrospective cohort study conducted advanced carcinoma diagnosed between January 1, 2010, December 31, 2014, treated chemotherapy. Treatment-related regression determined according 3-tier CRS, results were compared standard...

10.1097/igc.0000000000000945 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2017-04-08
Eunyoung Kang Ashley Weir Nicola S. Meagher Kyo Farrington Gregg Nelson and 95 more Prafull Ghatage Cheng‐Han Lee Marjorie J. Riggan Adelyn Bolithon Gordana Popović Betty Leung Katrina Tang Neil Lambie Joshua Millstein Jennifer Alsop Michael S. Anglesio Beyhan Ataseven Ellen Barlow Matthias W. Beckmann Jessica Berger Christiani Bisinotto Hans Bösmüller Jessica Boros Alison H. Brand Angela Brooks‐Wilson Sara Y. Brucker Michael E. Carney Yovanni Casablanca Alicia Cazorla Paul A. Cohen Thomas P. Conrads Linda S. Cook Penny Coulson Madeleine Courtney‐Brooks Daniel W. Cramer Philip Crowe Julie M. Cunningham Cezary Cybulski Kathleen M. Darcy Mona A. El‐Bahrawy Esther Elishaev Ramona Erber Rhonda Farrell Sián Fereday Anna Fischer María J. García Simon A. Gayther Aleksandra Gentry‐Maharaj C. Blake Gilks Marcel Grube Paul R. Harnett Shariska P. Harrington Philipp Harter Arndt Hartmann Jonathan L. Hecht Sebastian Heikaus Alexander Hein Florian Heitz Joy Hendley Brenda Y. Hernandez Susanna Hernando Polo Sabine Heublein Akira Hirasawa Estrid Høgdall Claus Høgdall Hugo M. Horlings David G. Huntsman Tomasz Huzarski Andrea Jewell Mercedes Jimenez‐Liñan Michael E. Jones Scott H. Kaufmann Catherine J. Kennedy Dineo Khabele F. Kommoss Roy F.P.M. Kruitwagen Diether Lambrechts Nhu D. Le Marcin Lener Jenny Lester Yee Leung Anna Linder Liselore Loverix Jan Lubiński Rashna Madan G. Larry Maxwell Francesmary Modugno Susan L. Neuhausen Alexander Olawaiye Siel Olbrecht Sandra Oršulić J.M. Palacios Celeste Leigh Pearce Malcolm C. Pike Carmel M. Quinn Ganendra Raj Mohan Cristina Rodríguez‐Antona Matthias Ruebner Andy Ryan Stuart Salfinger

Abstract Background Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo‐ovarian high‐grade serous carcinoma (HGSC). Smaller studies have revealed unfavorable associations for CCNE1 amplification overexpression with survival, but to date no large‐scale, histotype‐specific validation has been performed. The hypothesis was that high‐level of overexpression, as well combination the two, are linked shorter overall survival HGSC. Methods Within Ovarian Tumor Tissue...

10.1002/cncr.34582 article EN cc-by Cancer 2022-12-26

To determine the frequency and distribution of Fallopian tube involvement in patients with ovarian metastases non-gynaecological origin. All tissue was processed for histological examination a consecutive series 31 The most common primary sites were appendix (n = 10) colon 7), stomach 6) breast 4). Twenty cases (65%) showed at least one type tubal spread. Mural (14 cases) but serosal, intra-vascular, intra-epithelial intra-lumenal spread also identified 12, 9, 8 11 respectively....

10.1111/j.1365-2559.2012.04194.x article EN Histopathology 2012-03-06
Coming Soon ...